GERN — Geron Corporation
NASDAQ · Healthcare · Biotechnology
$1.58
+$0.10 (+6.76%)
Geron Corporation (GERN) is a biotechnology company listed on NASDAQ. It is led by Dawn Carter Bir, based in 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404, with about 229 employees. Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Latest reported GERN revenue for 2025-09-30 was $47.2M. Net income was -$18.4M. Revenue was down 3.7% from 2025-06-30 to 2025-09-30. GERN currently screens at market cap $878.9M.
Use this GERN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the GERN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the GERN SEC filings page. Lician reads the product cache first so this HTML stays unique to Geron Corporation even when a live quote feed is slow.
About Geron Corporation
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
GERN Key Statistics
Market Cap
$878.95M
Volume
3.51M
Previous Close
$1.55
Day Range
$1.50 – $1.57
EPS
-$0.27
Revenue
$0.00
Net Income
-$174.57M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-100.0%
Employees
229
GERN Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $237.00K | $596.00K | $1.39M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$174.57M | -$184.13M | -$141.90M | -$116.11M |
| EPS (Diluted) | -$0.27 | -$0.32 | -$0.37 | -$0.35 |
Total Assets
$593.78M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$79.02M
Operating Cash Flow
-$218.62M
Free Cash Flow
$0.00
Geron Corporation Company Information
- Interim President & Chief Executive Officer and Director
- Dawn Carter Bir
- Headquarters
- 919 East Hillsdale Boulevard, Foster City, CA, United States, 94404
- Website
- www.geron.com
- Phone
- 650 473 7700
- IPO / Founded
- 1996-06-30
- Sector
- Healthcare
- Industry
- Biotechnology